Biomarkers and Strain Echocardiography for the Detection of Subclinical Cardiotoxicity in Breast Cancer Patients Receiving Anthracyclines

Biomarkers and Strain Echocardiography for the Detection of Subclinical Cardiotoxicity in Breast Cancer Patients Receiving Anthracyclines

The optimal surveillance and management strategies for breast cancer patients receiving anthracycline therapy are limited by our incomplete understanding of the role of biomarkers heralding the onset of cardiotoxicity. The purpose of this study was to determine whether there is a temporal correlatio...

Full description

Bibliographic Details
Main Authors: Aditi A. Bhagat, Andreas P. Kalogeropoulos, Lea Baer, Matthew Lacey, Smadar Kort, Hal A. Skopicki, Javed Butler, Michelle Weisfelner Bloom
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Journal of Personalized Medicine
Subjects:
anthracycline cardiotoxicity
cardio-oncology
heart failure
biomarkers
Online Access:https://www.mdpi.com/2075-4426/13/12/1710

Similar Items

Similar Items